24-Jul-2007 - US biotech firm VaxInnate has been awarded a lump sum from the National Institutes of Health (NIH) to support the development of the company's tetravalent Dengue fever vaccine.
24-Jul-2007 - Roche has received a positive opinion from EU regulators recommending the approval of low-dose capsules of the blockbuster flu drug Tamiflu (oseltamivir), providing a more convenient dosage form for children.
23-Jul-2007 - Sanofi Pasteur has completed construction of its new facility in the US in a bid to meet an anticipated demand for seasonal influenza vaccine in the future.
23-Jul-2007 - A UK firm developing cannabis-derived multiple sclerosis (MS) treatments has decided to pull an EU application for its lead candidate Sativex, following demands by UK regulators for additional data in support of the treatment.
23-Jul-2007 - German speciality chemicals firm CABB has scooped up Swiss company SF-Chem in a deal set to create a leading European supplier of chlorine and speciality intermediates.
19-Jul-2007 - Fake internet pharmacies are a growing "global disaster" with increasingly dangerous consequences, pharmaceutical industry figures say.
18-Jul-2007 - Canadians finally have access to the controlled-release formulation of naproxen sodium, which has been on the US market for more than 10 years for the management of osteoarthritis and rheumatoid arthritis.
18-Jul-2007 - Biocon is targeting the global cell culture market with the production of pharmaceutical-grade insulin as a potent growth factor.
18-Jul-2007 - At a packed out session at last week's Controlled Release Society meeting in the US, two experts battled it out to win one of the key debates in gene delivery: which is superior - viral or non-viral delivery?
18-Jul-2007 - UK firm Acambis has announced that its universal influenza vaccine candidate has entered Phase I trials, hoping to prove a key weapon in the fight against pandemic flu and last-minute production panics.
17-Jul-2007 - Biopol Laboratory is acting to meet the demand of sneezes, itchy eyes and running noses as it consolidates its five allergen production facilities into one main building in Idaho.
17-Jul-2007 - Research being carried out at the University of Utrecht in the Netherlands to replace standard vaccination schedules with a single-shot alternative could do away with the need for repeated jabs.
16-Jul-2007 - A novel technology set to overcome the challenges of the blood brain barrier is being developed in a bid to open the gates to previously unusable compounds for the treatment of central nervous system (CNS) disorders.
16-Jul-2007 - An Israeli drug delivery firm is developing a new vaginal drug delivery system, making use of bio-adhesive foams to offer a more convenient and effective treatment option for women with gynaecological complaints.
12-Jul-2007 - BioSante Pharmaceuticals' vaccine adjuvant is coming up trumps as vaccine manufacturers race towards finding the most efficient bird flu vaccine.
12-Jul-2007 - The European generics market is expected to boom to $35.9bn (€26.1bn) in 2013, according to a Frost & Sullivan report.
11-Jul-2007 - US-based AlphaVax has been awarded a $3.6m grant from a US Government health agency to develop a new adjuvant technology for vaccines.
10-Jul-2007 - A new generation of therapeutic protein products has entered the biopharma scene and are proving more efficient than antibodies when using the same drug delivery systems.
10-Jul-2007 - Indian pharmaceutical manufacturing company Shasun Chemicals and Drugs has now got its eye fully on the US market after recent approval of its new formulation facility in Puducherry.
05-Jul-2007 - AstraZeneca is planning to gradually withdraw from making its own active pharmaceutical ingredients (APIs) and will use China as the pinnacle of its new outsourcing plans.
05-Jul-2007 - Taminco, UCB's old intermediates and derivatives unit, has been sold at auction to European investment group CVC Capital Partners for €0.8bn.
04-Jul-2007 - The International Society for Pharmaceutical Engineering (ISPE) has launched a new initiative to help implement the International Conference on Harmonization (ICH) guidelines.
04-Jul-2007 - Australia is soon to boast the largest monoclonal antibody production facility in the Southern Hemisphere, which will go some way in alleviating the increasing demand for the biologic agents.
02-Jul-2007 - One of the most significant deals to take place in the vaccine industry in the last ten years was signed late last night between vaccine heavyweight Novartis and biotech firm Intercell.
02-Jul-2007 - A new and improved extended-release treatment for schizophrenia has been granted marketing authorisation by the European Commission. Invega (paliperidone) is a once-daily formulation that will be marketed by J&J subsidiary, Janssen-Cilag.